Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 19, 2019 - Issue 7
Submit an article Journal homepage
4,897
Views
15
CrossRef citations to date
0
Altmetric
Review

Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology

Gabriele Di SantePennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, Wynnewood, PA, USAView further author information
,
Jessica PagéXavier University School of Medicine, Woodbury, NY, USAView further author information
,
Xuanmao JiaoPennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, Wynnewood, PA, USAView further author information
,
Omar NawabPennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, Wynnewood, PA, USA;Xavier University School of Medicine, Woodbury, NY, USAView further author information
,
Massimo CristofanilliDepartment of Medicine-Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USAView further author information
,
Emmanuel SkordalakesWistar Institute, Philadelphia, PA, USAView further author information
&
Richard G PestellPennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Pennsylvania Biotechnology Center, Wynnewood, PA, USA;Xavier University School of Medicine, Woodbury, NY, USA;Lee Kong Chian School of Medicine, Nanyang Technological University, SingaporeCorrespondence[email protected]
View further author information
 show all
Pages 569-587 | Received 20 Feb 2019, Accepted 03 May 2019, Published online: 20 Jun 2019

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Annat Raiter, Oran Zlotnik, Julia Lipovetsky, Shany Mugami, Shira Dar, Ido Lubin, Eran Sharon, Cyrille J. Cohen & Rinat Yerushalmi. (2021) A novel role for an old target: CD45 for breast cancer immunotherapy. OncoImmunology 10:1.
Read now

Articles from other publishers (14)

Marina Elena Cazzaniga, Antonio Ciaccio, Romano Danesi, Francois P. Duhoux, Corrado Girmenia, Kalhil Zaman, Henrik Lindman, Fabrizio Luppi, Dimitrios Mavroudis, Ida Paris, Ayodele Olubukola, Ahmed Samreen, Christian Schem, Christian Singer & Anton Snegovoy. (2023) Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project. Frontiers in Oncology 13.
Crossref
Jaime M. Pita, Eric Raspé, Katia Coulonval, Myriam Decaussin-Petrucci, Maxime Tarabichi, Geneviève Dom, Frederick Libert, Ligia Craciun, Guy Andry, Laurence Wicquart, Emmanuelle Leteurtre, Christophe Trésallet, Laura A. Marlow, John A. Copland, Cosimo Durante, Carine Maenhaut, Branca M. Cavaco, Jacques E. Dumont, Giuseppe Costante & Pierre P. Roger. (2023) CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas. Frontiers in Endocrinology 14.
Crossref
Rasha Hamid, Mustafa Alaziz, Amanpreet S. Mahal, Anthony W. Ashton, Niels Halama, Dirk Jaeger, Xuanmao Jiao & Richard G. Pestell. (2023) The Role and Therapeutic Targeting of CCR5 in Breast Cancer. Cells 12:18, pages 2237.
Crossref
Siyu Chen, Ping Leng, Jinlin Guo & Hao Zhou. (2023) FBXW7 in breast cancer: mechanism of action and therapeutic potential. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Shanshan Zhu, Tian Zhang, Huan Gao, Guorui Jin, Jin Yang, Xiaocong He, Hui Guo & Feng Xu. (2023) Combination Therapy of Lox Inhibitor and Stimuli‐Responsive Drug for Mechanochemically Synergistic Breast Cancer Treatment. Advanced Healthcare Materials 12:21.
Crossref
Mary Abdelmalak, Rajanbir Singh, Mohammed Anwer, Pavel Ivanchenko, Amritdeep Randhawa, Myra Ahmed, Anthony W. Ashton, Yanming Du, Xuanmao Jiao & Richard Pestell. (2022) The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy Resistance. Cancers 14:21, pages 5388.
Crossref
Khashayar Roohollahi, Yvonne de Jong, Saskia E. van Mil, Armida W.M. Fabius, Annette C. Moll & Josephine C. Dorsman. (2022) High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures. Ophthalmology Science 2:3, pages 100188.
Crossref
Bhawna Uprety & Heidi Abrahamse. (2022) Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights. Cells 11:3, pages 576.
Crossref
Cheng Liu, Ziyi Yang, Mingyu Liu, Xiangwei Wang, Shaoli Song, Xiaoping Xu & Zhongyi Yang. (2021) Gallium-68 Labeling of the Cyclin-Dependent Kinase 4/6 Inhibitors as Positron Emission Tomography Radiotracers for Tumor Imaging. ACS Omega 6:47, pages 32253-32261.
Crossref
Linda Yu, Jingli Liu, Yitang Yan, Alanna Burwell, Lysandra Castro, Min Shi & Darlene Dixon. (2021) “Metalloestrogenic” effects of cadmium downstream of G protein-coupled estrogen receptor and mitogen-activated protein kinase pathways in human uterine fibroid cells. Archives of Toxicology 95:6, pages 1995-2006.
Crossref
Soyoung Hur, Eungyeong Jang & Jang-Hoon Lee. (2021) Beneficial Actions of Orostachys japonica and Its Compounds against Tumors via MAPK Signaling Pathways. Nutrients 13:2, pages 555.
Crossref
Bethi Rathnakar, Gajula S. Kumar, Saleem P. Mahammad, Sridhar Gattu, Sambaru Kalyani, Rameshwar Nimma & Mavurapu Satyanarayana. (2020) Design, synthesis, and evaluation of novel combretastatin A‐4 based chalcone derivatives as anticancer agents. Journal of Heterocyclic Chemistry 58:2, pages 488-501.
Crossref
Ke Chen, Xuanmao Jiao, Agnese Di Rocco, Duanwen Shen, Shaohua Xu, Adam Ertel, Zuoren Yu, Gabriele Di Sante, Min Wang, Zhiping Li, Timothy G. Pestell, Mathew C. Casimiro, Emmanuel Skordalakes, Samuel Achilefu & Richard G. Pestell. (2020) Endogenous Cyclin D1 Promotes the Rate of Onset and Magnitude of Mitogenic Signaling via Akt1 Ser473 Phosphorylation. Cell Reports 32:11, pages 108151.
Crossref
Arndt Wallmann & Christopher Kesten. (2020) Common Functions of Disordered Proteins across Evolutionary Distant Organisms. International Journal of Molecular Sciences 21:6, pages 2105.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.